Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Cytoskeleton Reorganization as an Alternative Mechanism of Store-Operated Calcium Entry Control in Neuroendocrine-Differentiated Cells

  • Karine Vanoverberghe ,

    Contributed equally to this work with: Karine Vanoverberghe, V’yacheslav Lehen’kyi, Stéphanie Thébault, Maylis Raphaël

    Affiliations Inserm, U-1003, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d’Ascq, France, Laboratory of Excellence, Ion Channels Science and Therapeutics, Université des Sciences et Technologies de Lille (USTL), Villeneuve d’Ascq, France

  • V’yacheslav Lehen’kyi ,

    Contributed equally to this work with: Karine Vanoverberghe, V’yacheslav Lehen’kyi, Stéphanie Thébault, Maylis Raphaël

    Affiliations Inserm, U-1003, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d’Ascq, France, Laboratory of Excellence, Ion Channels Science and Therapeutics, Université des Sciences et Technologies de Lille (USTL), Villeneuve d’Ascq, France

  • Stéphanie Thébault ,

    Contributed equally to this work with: Karine Vanoverberghe, V’yacheslav Lehen’kyi, Stéphanie Thébault, Maylis Raphaël

    Affiliations Inserm, U-1003, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d’Ascq, France, Laboratory of Excellence, Ion Channels Science and Therapeutics, Université des Sciences et Technologies de Lille (USTL), Villeneuve d’Ascq, France

  • Maylis Raphaël ,

    Contributed equally to this work with: Karine Vanoverberghe, V’yacheslav Lehen’kyi, Stéphanie Thébault, Maylis Raphaël

    Affiliations Inserm, U-1003, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d’Ascq, France, Laboratory of Excellence, Ion Channels Science and Therapeutics, Université des Sciences et Technologies de Lille (USTL), Villeneuve d’Ascq, France

  • Fabien Vanden Abeele,

    Affiliations Inserm, U-1003, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d’Ascq, France, Laboratory of Excellence, Ion Channels Science and Therapeutics, Université des Sciences et Technologies de Lille (USTL), Villeneuve d’Ascq, France

  • Christian Slomianny,

    Affiliations Inserm, U-1003, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d’Ascq, France, Laboratory of Excellence, Ion Channels Science and Therapeutics, Université des Sciences et Technologies de Lille (USTL), Villeneuve d’Ascq, France

  • Pascal Mariot,

    Affiliations Inserm, U-1003, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d’Ascq, France, Laboratory of Excellence, Ion Channels Science and Therapeutics, Université des Sciences et Technologies de Lille (USTL), Villeneuve d’Ascq, France

  • Natalia Prevarskaya

    natacha.prevarskaya@univ-lille1.fr

    Affiliations Inserm, U-1003, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d’Ascq, France, Laboratory of Excellence, Ion Channels Science and Therapeutics, Université des Sciences et Technologies de Lille (USTL), Villeneuve d’Ascq, France

Abstract

Neuroendocrine differentiation (NED) is a hallmark of advanced androgen-independent prostate cancer, for which no successful therapy exists. NED tumour cells escape apoptotic cell death by alterations of Ca2+ homeostasis where the store-operated Ca2+ entry (SOCE) is known to be a key event. We have previously shown that the downregulation of Orai1 protein representing the major molecular component of endogenous SOCE in human prostate cancer cells, and constituting the principal source of Ca2+ influx used by the cell to trigger apoptosis, contributes to the establishment of an apoptosis-resistant phenotype (Cell Death Dis. 2010 Sep 16;1:e75.). Here, we report for the first time that the decrease of SOCE during NED may be caused by alternative NED-induced mechanism involving cytoskeleton reorganisation. NED induced by androgen deprivation resulted in a decrease of SOCE due to cortical F-actin over-polymerization which inhibits thapsigargin-induced SOCE. The disruption of F-actin polymerization by Cytochalasin D in NED cells restored SOCE, while the induction of F-actin polymerization by jasplakinolide or calyculin A diminished SOCE without changing the expression of key SOCE players: Orai1, STIM1, and TRPC1. Our data suggest that targeting cytoskeleton-induced pathways of malignant cells together with SOCE-involved channels may prove a useful strategy in the treatment of advanced prostate cancer.

Introduction

Neuroendocrine differentiation (NED) is a process which occurs in several types of carcinomas. Prostatic carcinoma belongs to the tumours in which NED is suggested as an indicator of poor prognostic as the rate of NED of prostate cancer cells increases with the grade of the prostate cancer [1], [2], [3]. Even though NED is the subject of intense research, the molecular and cellular mechanisms involved in this process remain unclear.

Prostate cancer (PCa), the second cause of cancer-related men disease in western countries, depends on androgen in the early stages. Androgen deprivation therapies also cause prostate tumour regression. However, such treatments become unsuccessful when PCa cells progress to an androgen-independent stage [4]. Therefore, assessing the mechanisms occurring during the evolution to androgen-independence appears to be crucial. We and others have previously demonstrated that the androgen-dependent LNCaP (Lymph Node Carcinoma of the Prostate, [5] PCa epithelial cells acquire NED characteristics in response to long-term androgen ablation [6], [7], [8].

It is well known that as NED cells are androgen-independent [9] and characterized by an apoptotic cell death resistance [10], [11]. Tumour enrichment in NED cells enhances the malignant potential and drastically affects cancer cell responsiveness to androgen ablation therapy [12]. Normally present in the healthy prostate where they participate in the development and in the regulation of secretary processes of the mature gland, NED cells display structural, functional and morphological characteristics of neurons [12], [13], [14]. Their resistance to apoptosis does not seem to involve anti-apoptotic oncoprotein bcl-2 overexpression but rather the discovered survival proteins such as survivin and clusterin [15], [16], [17]. Despite these data, continuing effort is required to determine all characteristic features of NED cell apoptosis-resistance in an attempt to find new targets for therapeutic intervention in advanced PCa.

We previously demonstrated that NED of LNCaP cells induced alterations in Ca2+ homeostasis including reduced filling of the endoplasmic reticulum (ER) Ca2+ store, decreased expression of the endolemmal SERCA 2b Ca2+ ATPase and the luminal Ca2+ binding calreticulin and down-regulated store-operated current (ISOC) [18]. Moreover, NED LNCaP cells display a thapsigargin- (Tg) induced apoptosis resistance. It is well established that Tg induces apoptosis by depleting ER Ca2+ store followed by a store-operated or capacitative Ca2+ entry (SOCE or CCE) carried by SOC channels [19]. One of them Orai1, represents the major molecular component of endogenous SOCE in human PCa cells, and constitutes the principal source of Ca2+ influx used by the cell to trigger apoptosis [20]. The downregulation of Orai1, and consequently SOCE, protected the cells from diverse apoptosis-inducing pathways, such as those induced by thapsigargin (Tg), tumour necrosis factor α, and cisplatin/oxaliplatin. Orai1 rescue, following Orai1 transfection of steroid-deprived cells, re-established the store-operated channel current and restored the normal rate of apoptosis, suggesting its role in the establishment of an apoptosis-resistant phenotype in PCa cells. Thus, the apoptosis resistance of androgen-independent PCa cells is associated with the downregulation of Orai1 expression as well as SOCE. On the other hand, the TRP (transient receptor potential) proteins family which is widely distributed in mammalian tissues [21] is currently known to play an crucial role in the generation of SOCE. Even though their physiological mechanisms of activation and regulation are still unclear, several processes have been proposed to explain SOCE regulation: at the level of TRP proteins expression, or TRP channel activity regulation by accessory proteins [22], [23], or by TRPC channels internalization/membrane insertion caused by cytoskeleton reorganization [24], [25], [26], [27], [28], [29]. Indeed, it has been reported that TRPC channels activity involves their integration in plasmalemmal signaling complexes [30], [31], whose stability depends at least on cytoskeleton integrity, especially the actin polymerization. In this respect and as TRP channels and Orai1 play a key role in SOCE which is one of the pro-apoptotic pathway in NED cells we sought to study how cytoskeleton rearrangements may influence the activity of SOCE, the NED itself, and consequently apoptosis resistance of PCa cells.

Materials and Methods

Cell Culture

LNCaP cells from the American Type Culture Collection were cultured in RPMI 1640 medium (Biowhittaker, Fontenay sous Bois, France) supplemented with 5 mM L-glutamine (Sigma, L’Isle d’Abeau, France) and 10% fetal bovine serum (Seromed, Poly-Labo, Strasbourg, France). The culture medium also contained 50,000 IU/l penicillin and 50 mg/l streptomycin. Cells were routinely grown in 50 ml flasks (Nunc, Poly- labo) and kept at 37°C in a humidified incubator in an air/CO2 (95/5%) atmosphere. For Ca2+ imaging experiments, the cells were subcultured in Petri dishes (Nunc) coated with polyornithine (Sigma, 5 mg/l) and used after 3 to 6 days. Prior to fluorescence measurements, the cells were removed from the culture flasks with 0.05% trypsin (Life Technologies, Cergy Pontoise, France) and cultivated on glass coverslips in the same culture medium.

Charcoal Stripped Medium

Tubes containing charcoal 10% (w/v) and FBS were agitated for 16 hours at 4°C. Following 1 hour of centrifugation at 10000 g and 4°C, the supernatant was collected and centrifuged again for 30 min at 27000 g. The resultant supernatant was filtrated through 0.22 µm filters. Before use, the charcoal stripped FBS was decomplemented for 30 min at 56°C. The charcoal stripped culture was obtained using charcoal stripped FBS and RPMI 1640 without Phenol Red, for 4 days.

Calcium Imaging

[Ca2+]i was measured using fura-2 (the detailed procedure has been described previously, [32]). The extracellular solution contained: NaCl-120, KCl-6, CaCl2-2, MgCl2-2, HEPES-10, and glucose-12. For Ca2+-free HBSS, CaCl2 was removed and EGTA (0.5 mM) added.

Electrophysiological Recordings

Membrane currents in LNCaP cells were recorded in the whole-cell configuration using the patch-clamp technique, and also using a computer-controlled EPC-9 amplifier (HEKA Electronic, Germany) as described previously [33] Patch pipettes were made on a P-97 puller (Sutter, USA) from borosilicate glass capillaries (WPI, USA). Extracellular solution used to record Ca2+-carried ISOC contained (in mM): 120 NaCl, 5 KCl, 10 CaCl2, 2 MgCl2, 5 glucose, 10 HEPES (pH adjusted to 7.3 with TEA OH). The pipettes were filled with the basic intracellular pipette solution (in mM): 120 Cs Methane sulfonate, 10 CsCl, 10 HEPES, 10 BAPTA, 6 MgCl2 (pH adjusted to 7.2 with CsOH).

Immunostaining

Cells were cultivated on 14 mm diameter glass coverslips. After 4 days of culture, cells were rinsed once with PBS (pH7.5), fixed with 4% formaldehyde-1X PBS for 30 min, treated with 100 mM glycine-PBS for 30 min, permeabilized with methanol triton 1% for 20 min, and then washed three times with PBS. After washing, the samples were blocked with donkey serum for 30 min, then incubated with the FITC-phalloidin (1∶100) 1 hour at 37°C or overnight when cells are treated with pharmacological compounds. After washing, samples were then mounted on glass slides. Slides were examined on a confocal microscope (Zeiss LSM 510) equipped with an argon-krypton laser; 488 nm light was used for the excitation of the FITC-phalloidin, and images were collected using a 40X oil immersion objective.

Western-blotting

Subconfluent LNCaP cells were treated with an ice-cold lysis buffer containing: 10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 10 mM MgCl, 1 mM PMSF, 1% Nonidet P-40, and protease inhibitor cocktail from Sigma. The lysates were centrifuged 15,000×g at 4°C for 20 minutes, mixed with a sample buffer containing: 125 mM Tris-HCl pH 6.8, 4% SDS, 5% β-mercaptoethanol, 20% glycerol, 0.01% bromphenol blue, and boiled for 5 min at 95°C. Total protein samples were subjected to 10% SDS-PAGE and transferred to a nitrocellulose membrane by semi-dry Western blotting (Bio-Rad Laboratories). The membrane was blocked in a 5% milk containing TNT buffer (Tris-HCl, pH 7.5, 140 mM NaCl, and 0.05% Tween 20) overnight then probed using specific rabbit polyclonal anti-hStim1 (1∶250, BD Transduction Laboratories) and mouse monoclonal anti-β-actin (Lab Vision Co.) antibodies. The bands on the membrane were visualized using enhanced chemiluminescence method (1∶1000, Pierce Biotechnologies Inc.). Densitometric analysis was performed using a Bio-Rad image acquisition system (Bio-Rad Laboratories).

RT-PCR

Total RNA was isolated using the guanidium thiocyanate-phenol-chloroform extraction procedure. After DNase I (Life Technologies) treatment to eliminate genomic DNA, 2 µg of total RNA was reverse transcribed into cDNA at 42°C using random hexamer primers (Perkin Elmer) and MuLV reverse transcriptase (Perkin Elmer) in a 20 µl final volume, followed by PCR as described below. The PCR primers used to amplify hStim1, hOrai1, Orai2, Orai3 cDNAs as well as the primers for β-actin are specified in Table 1. PCR was performed on the RT-generated cDNA using a GeneAmp PCR System 2400 thermal cycler (Perkin Elmer). To detect different cDNAs, PCR was performed by adding 1 µl of the RT template to a mixture of (final concentrations): 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 2.5 mM MgCl2, 200 µM of each dNTP, 600 nM of sense and antisense primers, and 1 U AmpliTaq Gold (Perkin Elmer) in a final volume of 25 µl. DNA amplification conditions included an initial 5 min denaturation step at 95°C (which also activated the Gold variant of Taq Polymrase), and 33 cycles of 30 sec at 95°C, 30 sec at 59°C, 30 sec at 72°C, and finally 7 min at 72°C. Then, density measurements were performed with “Quantity one” software (Biorad) and the data were analyzed using Origin 7.0 (Microcal Software Inc., Northampton, MA, USA).

thumbnail
Table 1. Primers used for the for semiquantitative PCR and the real-time quantitative PCR (in italic script).

https://doi.org/10.1371/journal.pone.0045615.t001

Quantitative Real-time PCR

Quantitative real-time PCR of TRPC1, STIM1, Orai1 and HPRT mRNA transcripts was done using MESA GREEN qPCR MasterMix Plus for SYBR Assay (Eurogentec, France) on the Biorad CFX96 Real-Time PCR Detection System. The sequences of primers are indicated in Table 1. The HPRT gene was used as an endogenous control to normalize variations in RNA extractions, the degree of RNA degradation, and variability in RT efficiency. To quantify the results we used the comparative threshold cycle method ΔΔC(t).

Reagents and Chemicals

All chemicals were purchased from Sigma (l’Isle d’Abeau, France) except fura-2/AM and thapsigargin (France Biochem, Meudon, France).

Data Analysis and Statistics

Each experiment was repeated at least three times (n). The data were analyzed using PulseFit (HEKA Electronics, Germany) and Origin 7.0 (Microcal Software Inc., Northampton, MA, USA). Data are expressed as mean ± SEM. Statistical analysis was performed using ANOVA, and p<0.05 was considered as significant. Asterisks denote: * - p<0.05, and ** - p<0.01.

Results

As it was currently well established that long-term androgen deprivation induces the NED of LNCaP cells [6], [8], [18], [34], we have used a 4-days androgen deprivation by means of charcoal stripped culture medium, in order to induce NED of LNCaP cells (NED-LNCaP). The functional results obtained on NED-LNCaP cells were compared with regular androgen-dependent LNCaP cells (CT-LNCaP), which served as a control.

NED Downregulates Ca2+ Store-depletion and Subsequent Store-operated Ca2+ Entry

Our first aim was to determine the effect of NED on endoplasmic reticulum (ER) Ca2+ stores filling status. The cells were first bathed in a Ca2+-free buffered solution and then exposed to a SERCA pumps inhibitor, thapsigargin (Tg at 1 µM). Ca2+ was released from ER Ca2+ stores into the cytosol by Tg, leading to a transient increase in intracellular Ca2+ concentration. Subsequently, 2 mM extracellular Ca2+ was added in the perfusion to permit capacitative calcium entry (SOCE) following store depletion. In these experimental conditions, the NED treatment did not significantly affect the basal Ca2+ level in the absence of extracellular Ca2+ (52±1.7 nM in CT-LNCaP versus 45±1.6 nM in NED-LNCaP, n = 240). In contrast, a 4-days NE differentiation treatment induced a ∼30% decrease in both store depletion and CCE (CT-LNCaP, 311±16 nM and 1600±30 nM, n = 180 versus NED-LNCaP, 210±11 nM and 1090±46 nM, n = 253, Fig. 1A). A one-day NED treatment only affected CCE (CT-LNCaP 1946±22, n = 152 versus NED-LNCaP 1793±23, n = 135, Fig. 1B). These results are in accord to our previous data showing that NED caused significant modifications in Ca2+ homeostasis, as a reduced filling of the ER Ca2+ store and substantial ISOC down-regulation [18]. In the separate series of experiments we have checked the expression of SOCE key players as Orai1, Orai2, Orai3, and STIM1 using semiquantitative (Fig. 1E) and real-time quantitative PCR for Orai1 and STIM1 (Fig. 1F). Only Orai1 expression changed twice as we have previously published [20].

thumbnail
Figure 1. Regulation of Ca2+ homeostasis and F-actin polymerization in NED-LNCaP cells.

After 4 (A) or one (B) days of culture in a charcoal-stripped culture medium used to induce NED, the capacitative Ca2+ entry quantified by Ca2+ imaging is induced by the application of 1 µM Tg in the presence of 2 mM extracellulaire CaCl2. Asterisks denote statistical significance * - p<0.05; ** - p<0.01, n = 3, N = 30–40 cells, in triplicates. The presence of F-actin fibres was observed in both CT-LNCaP (C) and NED-LNCaP (D) using phalloidin-FITC. Scale bar equals 10 µM. n = 3. E, Expression of Orai1, STIM1, Orai2, and Orai3 as compared to β-Actin in LNCaP cells and NED-LNCaP cells using semiquantitative PCR. n = 2. F, Quantitative real-time PCR for Orai1 and STIM1 in LNCaP (CT) versus LNCaP-NED (NED), n = 3, * - P<0.05.

https://doi.org/10.1371/journal.pone.0045615.g001

NED Affects ER Ca2+ Stores Depletion through Actin Network Over-polymerization

During NED we and others have previously demonstrated that NED-LNCaP cells acquired dendritic-like extensions containing F-actin which is localized under the plasma membrane [7], [35], [36]. Our immunohistochemical staining using confocal microscopy showed over-polymerization of F-actin in NED-LNCaP cells (Fig. 1D) compared to CT-LNCaP cells (Fig. 1C). We have verified if in NED-LNCaP cells STIM1 is still able to form punctae upon ER Ca2+ store depletion. 1 µM TG was able to induce the formation of punctae upon 1 µM TG treatment during 2 minutes (Fig. 2). Thus, we have confirmed the formation of punctae by STIM1 in NED-LNCaP cells.

thumbnail
Figure 2. STIM1 forms punctae in NED-LNCaP cells upon induction of SOCE by TG.

(A) NED-LNCaP cells stimulated either with DMSO (left panel) or treated with 1 µM TG for 2 min and stained with STIM1 antibody. Scale bar equals 5 µM. n = 3. (B) Western-blotting showing the expression of STIM1 protein in LNCaP cells using the anti-STIM1 antibody. n = 1.

https://doi.org/10.1371/journal.pone.0045615.g002

We have shown above that NED of LNCaP cells decreased the Tg-evoked SOCE (Fig. 1). Pharmacological treatments that destabilize the cortical actin network (CytD) prevent the activation of SOCE [37]. Using cytochalasin D (CytD, 3 µM, 10 min at 37°C) allows to interfere with the cytoskeleton and depolymerise the actin network [38] in both CT- and NED-LNCaP cells which leads to disappearance of long stress fibres in CT-LNCaP cells (Fig. 3A, top panel). Although stress fibres were broken, the neurite outgrowth of NED-LNCaP cells seemed to be always present, suggesting that NED may involve microtubules (Fig. 3A, bottom panel). The effects of CytD on SOCE of NED-LNCaP measured on-line as compared to NED-LNCaP only are shown in Fig. 3B. Depolymerization of F-actin by CytD (3 µM for 10 min at 37°C) decreased the Tg-induced SOCE in CT-LNCaP cells (1556±37 nM for CT, n = 33 versus 1345±31 nM for CT-CytD, n = 40) and partially restored the Tg-induced SOCE in NED-LNCaP (620±63 nM for NED, n = 33 versus 871±90 nM for NED-CytD, n = 42) (Fig. 3C). Depolymerization of actin does not have the same effect on SOCE according to the differentiation status of LNCaP cells.

thumbnail
Figure 3. Cytochalasin D treatment disrupts the F-actin in both CT- and NED-LNCaP cells and partially restores the SOCE in differentiated LNCaP cells.

(A) CT-LNCaP (top panel) and NED-LNCaP cells (bottom panel) were treated with 5 µM Cyt D for 10 min at 37°C and stained for F-actin using phalloidin-FITC. Scale bar equals 10 µM. n = 3. (B) Histograms representing Tg-induced SOCE quantification in CT-, CT-CytD-, NED- and NED-CytD-LNCaP cells. The SOCE was quantified by the application of 1 µM Tg in the presence of 2 mM extracellular Ca2+. n = 3, N = 30–40 cells, in triplicates, * p<0.05. (C) Intracellular Ca2+ concentration measured in fura-2 loaded cells showing that depolymerization of F-actin in NED-CytD-LNCaP treated cells partially restores the amplitude of the SOCE.

https://doi.org/10.1371/journal.pone.0045615.g003

In patch-clamp experiments we intended to see whether the observed effects of NED and actin depolymerisation on SOCE correlate with the store-operated membrane current. Using whole-cell electrophysiological recording and TG-evoked SOCE we have shown (Fig. 4) that NED largely suppresses store-operated membrane currents (0.61±0.05 for NED-LNCaP versus 1.34±0.047 pA/pF in control LNCaP, n = 23) and actin depolymerisation by CytD (3 µM, 10 min) only partially restores it (1.02±0.06 versus 0.061±0.05 pA/pF in NED-LNCaP, n = 23). These results suggest that the over-polymerization of the cortical F-actin observed during the NED may be a key event in the down-regulation of the Tg-induced SOCE in NED-LNCaP cells.

thumbnail
Figure 4. Cytochalasine D (CytD) partially restores the store-operated current induced by TG.

(A) The whole-cell electrophysiological recordings of SOCE induced by 1 µM TG in LNCaP cells control (CT), NED (NED), and NED LNCaP cells treated with 3 µM CytD (NED-CytD). (B) Histograms showing the current density quantifications in the above conditions, n = 3, N = 23; in triplicates, ** - p<0.01.

https://doi.org/10.1371/journal.pone.0045615.g004

To validate this hypothesis, we tested the effect of actin polymerization on Tg-evoked SOCE by using jasplakinolide (JP). The polymerizating effect of JP on actin is presented in CT- and NED-LNCaP cells (Fig. 5A). JP treatment (5 µM for 1 hour at 37°C) reduced SOCE amplitude in both CT- (1079±209 nM for CT-JP, n = 40 versus 1577±83 for CT, n = 44) and NED-LNCaP cells (955±88 nM for NED, n = 52 versus 587±95 nM for NED-JP, n = 52; Fig. 5B). The most interesting point to note is that the amplitude of SOCE in JP-CT-LNCaP cells, resulting from actin polymerization, is similar to the amplitude of SOCE in NED-LNCaP cells.

thumbnail
Figure 5. F-actin polymerization by jaspakinolide (JP) in both control and NED-LNCaP cells.

(A) Representative images of immunofluorescence staining of F-actin with phalloidin-FITC in CT-, CT-JP (5 µM for 1 hour at 37°C), NED- and NED-JP-LNCaP cells. Scale bar equals 10 µM. n = 3. (B) Histograms representing Tg-induced SOCE quantification (Tg 1 µM, 2 mM extracellular Ca2+) in CT-, CT-JP-, NED- and NED-JP-LNCaP cells. n = 3, N = 30–40 cells, in triplicates. Asterisks denote statistical significance: * p<0.05.

https://doi.org/10.1371/journal.pone.0045615.g005

Further, we used calyculin A (CalA) which specifically blocks PP1 and PP2A phosphatases, inducing cytoskeleton reorganization similar to that induced by JP [39]. In many cell types, actin either becomes condensed at the plasma membrane or condenses into actin bundles inside the cells [40], [41]. The polymerizating effect of CalA on actin is presented in NED-LNCaP cells (Fig. 6A). Identical action is observed in CT-LNCaP cells (data not shown). In both CT-LNCaP and NED-LNCaP cells, Tg-induced SOCE was decreased by a rapid treatment with CalA (50 nM for 10 min) (Fig. 6B) (1352±41 nM for CalA-CT, n = 74 versus 1588±52 nM for CT, n = 66) and in NED-LNCaP cells (1119±50 nM for CalA-NED, n = 56 versus 1374±43 nM for NED, n = 62). These observations matched those described with a JP treatment.

thumbnail
Figure 6. F-actin polymerization by calyculin A (CalA) in both control and NED-LNCaP cells.

(A) Representative images of immunofluorescence staining of F-actin with phalloidin-FITC in NED- and NED-CalA (50 nM for 10 min)-LNCaP cells. n = 3. (B) Histograms representing Tg-induced SOCE quantification (Tg 1 µM, 2 mM extracellular Ca2+) in CT-, CT-CalA-, NED- and NED-CalA-LNCaP cells. n = 3, N = 30–40 cells, in triplicates. Asterisks denote statistical significance: * p<0.05.

https://doi.org/10.1371/journal.pone.0045615.g006

As it was previously mentioned, the most interesting finding is that JP-induced actin polymerization treatment mimics the down-regulatory effect of NED on SOCE in NED-LNCaP cells. This would indicate that the cytoskeleton reorganization may be one pathway used by NED to down-regulate SOC channels activity supporting SOCE in LNCaP cells.

Finally, to prove that during our treatments no transcription de novo takes place we have performed a real-time quantitative PCR using the primers for Orai1, STIM1, and TRPC1 (Fig. 7). Cells (LNCaP and NED-LNCaP) were stimulated with either CytD, 3 µM, 10 min or CalA 50 nM for 10 min both at 37°C, RNA was extracted, reverse-transcribed and a real-time quantitative PCR was performed. As we can see from the Fig. 7, no significant changes in Orai1, STIM1, and TRPC1 expression were detected in either CytD or CalA treated cells. Thus the cytoskeleton reorganisation may take a significant role in modulation of membrane currents and SOCE in both control and NED prostate cancer cells.

thumbnail
Figure 7. The expression of Orai1, STIM1 and TRPC1 does not change during CytD and CalA treatment in both LNCaP and NED-LNCaP.

(A) Real-time quantitative PCR for the Orai1 transcripts in both LNCaP and NED-LNCaP cells treated with 50 nM CalA for 10 min or 5 µM Cyt D for 10 min. (B) Real-time quantitative PCR for the STIM1 transcripts in both LNCaP and NED-LNCaP cells treated with 50 nM CalA for 10 min or 5 µM Cyt D for 10 min. (C) Real-time quantitative PCR for the TRPC1 transcripts in both LNCaP and NED-LNCaP cells treated with 50 nM CalA for 10 min or 5 µM Cyt D for 10 min. There was no statistical significance observed in each condition (LNCaP and NED-LNCaP). n = 3, done in triplicates.

https://doi.org/10.1371/journal.pone.0045615.g007

Discussion

In the present study we report two major findings characterizing the alternative pathway by which NED may contribute apoptosis resistance in PCa. Firstly, we describe that NED mediates SOCE down-regulation through cytosketon reorganization, especially F-actin over-polymerization. Secondly, we show that cytoskeleton reorganization is a pathway used by NED to down-regulate SOC channels activity without changing their expression.

NED and Calcium Homeostasis Linked by Cytoskeleton

The activation of SOCE is a signalling process of great relevance as this mechanism is a key event in physiological processes such as cellular proliferation and apoptosis [42]. In pioneer works [18], [43], we showed that NED of LNCaP cells induced by long-term androgen-deprivation decreases the well-characterized store-operated Ca2+ current (ISOC). Here, we confirm by Ca2+ imaging measurements that NED in the same conditions down-regulated the SOCE amplitude. In addition, we also show that the Tg-induced SOCE decrease may result from a decrease in Ca2+ stores depletion in NED-LNCaP cells.

Despite these data, the activation mechanisms of SOCE are still unclear. However, three main hypothesis are proposed to explain SOC channels activity regulation: one related to a diffusible messenger termed CIF (Calcium Influx Factor) [44]), the second involves a conformational coupling between the plasma membrane [45] and the ER and the last one supporting an exocytosis-related translocation of SOC channels [24], [25], [27], [28], [29]. It is known that the two last mechanisms involve cytoskeleton rearrangement [46] as cytoskeleton has been shown to modulate SOCE [47], [48]. Indeed, the accumulation of F-actin into a cortical layer under plasma membrane after treatment with calyculin A and jasplakinolide prevents SOC channels activation in several models [49], [50]. In addition, cell morphology has been shown to play an essential role in agonist-induced ER Ca2+ stores depletion in endothelial cells [48]. We first studied the potential cytoskeleton involvement in ER Ca2+ store depletion as this process is the key event in SOCE induction [51], [52]. We and others have previously shown that NED causes the rearrangement of the cortical F-actin [18], [53]. Our data show that actin polymerization enhances, whereas actin depolymerization decreases Tg-induced Ca2+ stores depletion in undifferentiated LNCaP cells. Our results correlate with those obtained by Wang et al. (2002) on primary hippocampal cell cultures [54]. As both polymerizing (jasplakinolide and calyculin A) and depolymerizing agents (cytochalasine D) affect Tg-evoked Ca2+ stores release whatever the differentiation status of LNCaP cells, we suggest that the Ca2+ stores depletion down-regulation in NED-LNCaP cells does not results from the actin over-polymerization.

Concerning SOCE, as previously mentioned, cytoskeleton can regulate SOCE in many cellular types [49], [51], [55]. Although CytD induces filaments depolymerization, its predominant effect is the induction of filaments dissociation from the plasma membrane [49]. In this case, we show that depolymerization of cortical F-actin and its detachment from the plasma membrane refreshes the SOCE in NED-LNCaP cells. In contrast, the stimulation of the polymerization of the cortical F-actin by JP potentiates the SOCE amplitude decrease. Furthermore, the SOCE amplitude of JP-CT-LNCaP cells is identical to that of NED-LNCaP cells. This suggests that the polymerization of F-actin due to JP reproduces the NED effect on LNCaP cell’s cytoskeleton. The results obtained in control cells are in agreement with studies on vascular endothelial cells and human platelets [47], [50]. The conflicting effect produced by the CytD in control and NED cells can be explained by the percentage of F-actin contained in cells and suggests that in control cell, the cytoskeleton is required for channel function. This may also suggest the involvement of physical-coupling model in SOCE induction.

It has been suggested that Cal A activates a translocation of existing F-actin to the cell periphery, independent of polymerization and consistent with the phosphorylation events described above [49]. In our model, this translocation seems to be grouped around a pole of the cell. In these conditions, CalA failed to exactly reproduce the JP effect. Therefore, we suggest that, under NED, cortical F-actin is desorganized exclusively at the cell periphery. In summary, our data strongly suggest that the cytoskeleton reorganization may be another pathway used by NED to down-regulate SOC channels activity without changing their expression and consequently downregulate SOCE in LNCaP cells.

Possible Mechanisms of SOCE-downregulation by NED

TRP (Transient Receptor Potential) protein family was shown to be involved in SOCE [46], [56], [57]. The mechanisms of TRP-channel regulation are still the subject of intense research as SOCE activation and down-regulation seems to be required in physiological processes such as immune response [27]. Several processes have been proposed to explain SOCE regulation: at the level of TRP proteins expression [58], activity regulation of TRP channels due to accessory proteins [59], [60] or by TRPC channels internalization/membrane insertion caused by cytoskeleton reorganization [24], [25], [26], [27], [28], [29]. TRP proteins are characterized by an ankyrin domain permitting the connection of proteins to the cytoskeleton. Consequently, modulations of the polymerization state of the cortical F-actin could modulate the activation of the TRP proteins. Indeed, Lockwitch et al. have shown that the status of the actin cytoskeleton affects the localization of the TRPC3-associated signalling complex. These authors suggest that stabilization of cortical actin induces internalization of TRPC3 and induces the loss of calcium influx [61]. Thus, TRP-channel internalization by the cytoskeleton reorganization may be proposed as a pathway used by NED to down-regulate SOC channels activity and consequently SOCE in prostate cancer cells.

Implications for Androgen-independent Prostate Cancer

Apoptosis is essential in maintaining tissue homeostasis. The acquisition of a resistance to apoptosis plays a pivotal role in tumor genesis by disrupting the balance between cell proliferation and cell death. Androgen-independent prostate cancer is characterized by tumor enrichment in apoptosis resistant cell phenotypes as NED cells. Anti-apoptotic mechanisms involve basic changes in intracellular Ca2+ homeostasis as ISOC down-regulation during the NED of prostate cancer epithelial cells [18]. In addition, we have previously identified TRPC1 and TRPC4 as proteins involved in Tg-evoked ISOC in LNCaP cells [52], and demonstrated that NED LNCaP cells display a thapsigargin- (Tg) induced apoptosis resistance [18]. Our latest work showed Orai1 protein represents the major molecular component of endogenous store-operated Ca2+ entry in human prostate cancer cells, and constitutes the principal source of Ca2+ influx used by the cell to trigger apoptosis [20]. The functional coupling of STIM1 to Orai1, as well as Orai1 Ca2+-selectivity as a channel, is required for its pro-apoptotic effects we have also shown that the apoptosis resistance of androgen-independent PCa cells is associated with the downregulation of Orai1 expression as well as SOCE. Thought, in our recent work we clearly show that the alternative cytoskeleton-related mechanism may exist employing the downregulation of SOCE without changing the expression of neither Orai1 nor STIM1, nor TRPC1.

In conclusion, in the present study we show that the NED of LNCaP cells induced actin network over-polymerization resulting in SOCE down-regulation. Taken together, these results suggest the existence of an alternative regulation pathway for the control of SOCE which is most probably implicated in apoptosis-resistance of NED-LNCaP cells and consequently the apoptotic status of neuro-endocrine cells in advanced, androgen-independent prostate cancer.

Author Contributions

Conceived and designed the experiments: VL PM NP. Performed the experiments: KV MR FVA CS ST. Analyzed the data: KV VL MR. Wrote the paper: VL ST NP.

References

  1. 1. di Sant’Agnese PA, Cockett AT (1996) Neuroendocrine differentiation in prostatic malignancy. Cancer 78: 357–361.
  2. 2. Cohen RJ, Glezerson G, Haffejee Z (1991) Neuro-endocrine cells–a new prognostic parameter in prostate cancer. Br J Urol 68: 258–262.
  3. 3. Tarle M, Frkovic-Grazio S, Kraljic I, Kovacic K (1994) A more objective staging of advanced prostate cancer–routine recognition of malignant endocrine structures: the assessment of serum TPS, PSA, and NSE values. Prostate 24: 143–148.
  4. 4. Feldman BJ, Feldman D (2001) The development of androgen-independent prostate cancer. Nat Rev Cancer 1: 34–45.
  5. 5. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, et al. (1983) LNCaP model of human prostatic carcinoma. Cancer Res 43: 1809–1818.
  6. 6. Burchardt T, Burchardt M, Chen MW, Cao Y, de la Taille A, et al. (1999) Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo. J Urol 162: 1800–1805.
  7. 7. Mariot P, Vanoverberghe K, Lalevee N, Rossier MF, Prevarskaya N (2002) Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells. J Biol Chem 277: 10824–10833.
  8. 8. Zelivianski S, Verni M, Moore C, Kondrikov D, Taylor R, et al. (2001) Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype. Biochim Biophys Acta 1539: 28–43.
  9. 9. Bonkhoff H (2001) Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status. Ann Oncol 12 Suppl 2S141–144.
  10. 10. Fixemer T, Remberger K, Bonkhoff H (2002) Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma. Prostate 53: 118–123.
  11. 11. Raffo AJ, Perlman H, Chen MW, Day ML, Streitman JS, et al. (1995) Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res 55: 4438–4445.
  12. 12. Abrahamsson PA (1999) Neuroendocrine cells in tumour growth of the prostate. Endocr Relat Cancer 6: 503–519.
  13. 13. di Sant’Agnese PA (1992) Neuroendocrine differentiation in human prostatic carcinoma. Hum Pathol 23: 287–296.
  14. 14. di Sant’Agnese PA (1998) Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: a review of morphologic aspects. Urology 51: 121–124.
  15. 15. Xue Y, Verhofstad A, Lange W, Smedts F, Debruyne F, et al. (1997) Prostatic neuroendocrine cells have a unique keratin expression pattern and do not express Bcl-2: cell kinetic features of neuroendocrine cells in the human prostate. Am J Pathol 151: 1759–1765.
  16. 16. Xing N, Qian J, Bostwick D, Bergstralh E, Young CY (2001) Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin. Prostate 48: 7–15.
  17. 17. July LV, Akbari M, Zellweger T, Jones EC, Goldenberg SL, et al. (2002) Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy. Prostate 50: 179–188.
  18. 18. Vanoverberghe K, Vanden Abeele F, Mariot P, Lepage G, Roudbaraki M, et al. (2004) Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells. Cell Death Differ 11: 321–330.
  19. 19. Putney JW Jr (1986) A model for receptor-regulated calcium entry. Cell Calcium 7: 1–12.
  20. 20. Flourakis M, Lehen’kyi V, Beck B, Raphael M, Vandenberghe M, et al. (2010) Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cells. Cell Death Dis 1: e75.
  21. 21. Clapham DE (2003) TRP channels as cellular sensors. Nature 426: 517–524.
  22. 22. Boulay G (2002) Ca(2+)-calmodulin regulates receptor-operated Ca(2+) entry activity of TRPC6 in HEK-293 cells. Cell Calcium 32: 201–207.
  23. 23. Singh BB, Liu X, Tang J, Zhu MX, Ambudkar IS (2002) Calmodulin regulates Ca(2+)-dependent feedback inhibition of store-operated Ca(2+) influx by interaction with a site in the C terminus of TrpC1. Mol Cell 9: 739–750.
  24. 24. Ambudkar IS (2004) Cellular domains that contribute to Ca2+ entry events. Sci STKE 2004: pe32.
  25. 25. Ambudkar IS, Brazer SC, Liu X, Lockwich T, Singh B (2004) Plasma membrane localization of TRPC channels: role of caveolar lipid rafts. Novartis Found Symp 258: 63–70; discussion 70–64, 98–102, 263–106.
  26. 26. Brazer SC, Singh BB, Liu X, Swaim W, Ambudkar IS (2003) Caveolin-1 contributes to assembly of store-operated Ca2+ influx channels by regulating plasma membrane localization of TRPC1. J Biol Chem 278: 27208–27215.
  27. 27. Itagaki K, Kannan KB, Singh BB, Hauser CJ (2004) Cytoskeletal reorganization internalizes multiple transient receptor potential channels and blocks calcium entry into human neutrophils. J Immunol 172: 601–607.
  28. 28. Cayouette S, Lussier MP, Mathieu EL, Bousquet SM, Boulay G (2004) Exocytotic Insertion of TRPC6 Channel into the Plasma Membrane upon Gq Protein-coupled Receptor Activation. J Biol Chem 279: 7241–7246.
  29. 29. Bezzerides VJ, Ramsey IS, Kotecha S, Greka A, Clapham DE (2004) Rapid vesicular translocation and insertion of TRP channels. Nat Cell Biol 6: 709–720.
  30. 30. Montell C (2004) Exciting trips for TRPs. Nat Cell Biol 6: 690–692.
  31. 31. Montell C (2004) Molecular genetics of Drosophila TRP channels. Novartis Found Symp 258: 3–12; discussion 12–17, 98–102, 263–106.
  32. 32. Skryma R, Mariot P, Bourhis XL, Coppenolle FV, Shuba Y, et al. (2000) Store depletion and store-operated Ca2+ current in human prostate cancer LNCaP cells: involvement in apoptosis. J Physiol 527 Pt 1: 71–83.
  33. 33. Vanden Abeele F, Lemonnier L, Thebault S, Lepage G, Parys JB, et al. (2004) Two types of store-operated Ca2+ channels with different activation modes and molecular origin in LNCaP human prostate cancer epithelial cells. J Biol Chem 279: 30326–30337.
  34. 34. Bang YJ, Pirnia F, Fang WG, Kang WK, Sartor O, et al. (1994) Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Proc Natl Acad Sci U S A 91: 5330–5334.
  35. 35. Rumpold H, Heinrich E, Untergasser G, Hermann M, Pfister G, et al. (2002) Neuroendocrine differentiation of human prostatic primary epithelial cells in vitro. Prostate 53: 101–108.
  36. 36. Hsieh TC, Xu W, Chiao JW (1995) Growth regulation and cellular changes during differentiation of human prostatic cancer LNCaP cells as induced by T lymphocyte-conditioned medium. Exp Cell Res 218: 137–143.
  37. 37. Sanada M, Matsuura H, Omatsu-Kanbe M, Sango K, Kashiwagi A, et al. (2004) Cytosolic Ca2+ under high glucose with suppressed Na+/K+ pump activity in rat sensory neurons. Neuroreport 15: 197–201.
  38. 38. Prentki M, Chaponnier C, Jeanrenaud B, Gabbiani G (1979) Actin microfilaments, cell shape, and secretory processes in isolated rat hepatocytes. Effect of phalloidin and cytochalasin D. J Cell Biol 81: 592–607.
  39. 39. Hirano K, Chartier L, Taylor RG, Allen RE, Fusetani N, et al. (1992) Changes in the cytoskeleton of 3T3 fibroblasts induced by the phosphatase inhibitor, calyculin-A. J Muscle Res Cell Motil 13: 341–353.
  40. 40. Kreienbuhl P, Keller H, Niggli V (1992) Protein phosphatase inhibitors okadaic acid and calyculin A alter cell shape and F-actin distribution and inhibit stimulus-dependent increases in cytoskeletal actin of human neutrophils. Blood 80: 2911–2919.
  41. 41. Shinoki N, Sakon M, Kambayashi J, Ikeda M, Oiki E, et al. (1995) Involvement of protein phosphatase-1 in cytoskeletal organization of cultured endothelial cells. J Cell Biochem 59: 368–375.
  42. 42. Berridge MJ (1995) Calcium signalling and cell proliferation. Bioessays 17: 491–500.
  43. 43. Vanden Abeele F, Skryma R, Shuba Y, Van Coppenolle F, Slomianny C, et al. (2002) Bcl-2-dependent modulation of Ca(2+) homeostasis and store-operated channels in prostate cancer cells. Cancer Cell 1: 169–179.
  44. 44. Smani T, Zakharov SI, Csutora P, Leno E, Trepakova ES, et al. (2004) A novel mechanism for the store-operated calcium influx pathway. Nat Cell Biol 6: 113–120.
  45. 45. Putney JW Jr (1999) “Kissin’ cousins”: intimate plasma membrane-ER interactions underlie capacitative calcium entry. Cell 99: 5–8.
  46. 46. Venkatachalam K, van Rossum DB, Patterson RL, Ma HT, Gill DL (2002) The cellular and molecular basis of store-operated calcium entry. Nat Cell Biol 4: E263–272.
  47. 47. Grimaldi M, Favit A, Alkon DL (1999) cAMP-induced cytoskeleton rearrangement increases calcium transients through the enhancement of capacitative calcium entry. J Biol Chem 274: 33557–33564.
  48. 48. Holda JR, Blatter LA (1997) Capacitative calcium entry is inhibited in vascular endothelial cells by disruption of cytoskeletal microfilaments. FEBS Lett 403: 191–196.
  49. 49. Patterson RL, van Rossum DB, Gill DL (1999) Store-operated Ca2+ entry: evidence for a secretion-like coupling model. Cell 98: 487–499.
  50. 50. Rosado JA, Sage SO (2000) Coupling between inositol 1,4,5-trisphosphate receptors and human transient receptor potential channel 1 when intracellular Ca2+ stores are depleted. Biochem J 350 Pt 3: 631–635.
  51. 51. Rosado JA, Lopez JJ, Harper AG, Harper MT, Redondo PC, et al. (2004) Two pathways for store-mediated calcium entry differentially dependent on the actin cytoskeleton in human platelets. J Biol Chem 279: 29231–29235.
  52. 52. Vanden Abeele F, Lemonnier L, Thebault S, Lepage G, Parys J, et al.. (2004) Two types of store-operated Ca2+ channels with different activation modes and molecular origin in LNCaP human prostate cancer epithelial cells. J Biol Chem.
  53. 53. Donald CD, Cooper CR, Harris-Hooker S, Emmett N, Scanlon M, et al. (2001) Cytoskeletal organization and cell motility correlates with metastatic potential and state of differentiation in prostate cancer. Cell Mol Biol (Noisy-le-grand) 47: 1033–1038.
  54. 54. Wang Y, Mattson MP, Furukawa K (2002) Endoplasmic reticulum calcium release is modulated by actin polymerization. J Neurochem 82: 945–952.
  55. 55. Wu S, Sangerman J, Li M, Brough GH, Goodman SR, et al. (2001) Essential control of an endothelial cell ISOC by the spectrin membrane skeleton. J Cell Biol 154: 1225–1233.
  56. 56. Peng JB, Brown EM, Hediger MA (2003) Epithelial Ca2+ entry channels: transcellular Ca2+ transport and beyond. J Physiol 551: 729–740.
  57. 57. Clapham DE, Runnels LW, Strubing C (2001) The TRP ion channel family. Nat Rev Neurosci 2: 387–396.
  58. 58. Putney JW, Jr., Trebak M, Vazquez G, Wedel B, Bird GS (2004) Signalling mechanisms for TRPC3 channels. Novartis Found Symp 258: 123–133; discussion 133–129, 155–129, 263–126.
  59. 59. Vennekens R, Hoenderop JG, Prenen J, Stuiver M, Willems PH, et al. (2000) Permeation and gating properties of the novel epithelial Ca(2+) channel. J Biol Chem 275: 3963–3969.
  60. 60. Nilius B, Prenen J, Vennekens R, Hoenderop JG, Bindels RJ, et al. (2001) Modulation of the epithelial calcium channel, ECaC, by intracellular Ca2+. Cell Calcium 29: 417–428.
  61. 61. Lockwich T, Singh BB, Liu X, Ambudkar IS (2001) Stabilization of cortical actin induces internalization of transient receptor potential 3 (Trp3)-associated caveolar Ca2+ signaling complex and loss of Ca2+ influx without disruption of Trp3-inositol trisphosphate receptor association. J Biol Chem 276: 42401–42408.